隶属于 catholic medical center
相关临床试验
75
10 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
进行中（未招募）
3
4.0%
已完成
22
29.3%
Enrolling By Invitation
3
4.0%
尚未招募
4
5.3%
招募中
4
5.3%
终止
2
2.7%
Unknown
37
49.3%
暂无批准数据
- A joint team from Seoul St. Mary's Hospital, the University of Seoul, and Flownics will develop quantum computing-based computational fluid dynamics (CFD) analysis for cardiovascular blood flow. - The project, funded with 2.5 billion won ($1.81 million) over 2026–2028, aims to achieve at least 95 percent precision in quantum-based CFD versus conventional CFD. - The research will initially focus on atrial fibrillation, the most common sustained arrhythmia affecting 2 to 3 percent of the general population. - The team plans to combine variational quantum algorithms, Krylov subspace methods, classical shadow measurement, and non-Markovian quantum error mitigation to identify real-world quantum advantage.
- Seoul St. Mary's Hospital has administered 200 antibody therapy treatments for Alzheimer's disease as of May, marking a significant clinical milestone. - The hospital operates a dual-department model with neurology and psychiatry serving as independent prescribing departments within a shared diagnostic infrastructure. - Patient care spans from precision diagnosis using amyloid PET to regular MRI safety monitoring and intravenous infusion, supported by radiology, nuclear medicine, and laboratory medicine. - Six professors across neurology and psychiatry are actively participating in the treatment program, demonstrating a multidisciplinary approach to Alzheimer's care.
